PHLDA2 and neoplasm: Thus, targeting PHLDA2 could potentially impede the recruitment of TAMs, reprogram the polarization of TAMs, and suppress Tregs-induced immune tolerance to enhance anti-tumor immunity, thereby reshaping the tumor immune microenvironment.